Advertisement
AZA may be effective option when triple therapy fails
Transplant patients face increased risk for osteoporosis
A new, precise biomarker for CV risk in psoriatic disease?
Disagreement on both sides of Atlantic about classic RCVS case
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Q&A with leaders of a new research collaboration
Case study sorts out the many possibilities to consider
Resources include international study and disease registry
Early focus will be selective TNF-α receptor inhibition
VERVE study aims for answers
Multiorgan involvement is the rule in vasculitis
Advertisement
Advertisement